Namibian Mining News The Professional Mining Journal
Related Articles
In a move set to redefine Namibia’s healthcare and industrial landscape, the Namibia Institute of Pathology Limited unveiled its pioneering Innovation Hub for Laboratory Consumables in Swakopmund. The facility, inaugurated on 23 May 2025, marks a decisive step toward reducing the country’s reliance on imported medical supplies while positioning Namibia as a regional leader in medical manufacturing.
Supported by a N$15 million investment, which includes a N$3 million grant from the German government and the European Union through GIZ, the NIP Innovation Hub will manufacture essential laboratory supplies including urine/stool cups and viral specimen tubes. Phase Two will grow into more sophisticated goods such serum separators for export throughout the SADC region, while Phase One will produce 2.7 million units in 2025 and 5.5 million by 2028.
In her remarks, NIP CEO Kapena Tjombonde emphasized the need for innovation, saying that the things that have led Namibia this far will not carry us forward for the next thirty-five years. She underlined that Namibia’s solution to preserving health sovereignty, saving lives, and reducing expenses is this hub.
The initiative, which prioritizes industrialization and local value addition, is in line with Namibia’s Vision 2030 and the Harambee Prosperity Plan II. The NIP Deputy Chairperson, Dr. Vaino Shivute, praised the facility as a statement of Namibia’s determination to eliminate reliance on imports, emphasizing its potential to benefit the 300 million people in SADC and generate employment in engineering, quality control, and logistics.
Erongo Governor Neville Andre highlighted the strategic relevance of the region, pointing out that this center would support families, foster skills through collaborations with NUST and UNAM, and stimulate SMEs in packaging and logistics, with eight direct employment now and over twenty in Phase Two. The fact that Swakopmund is close to NamPort guarantees effective distribution, supporting Erongo’s development as a hub for commerce and innovation.
NIP’s daring shift to local production was prompted by the COVID-19 pandemic, which revealed Namibia’s susceptibility to interruptions in the worldwide supply chain. Namibia’s health security will no longer be dependent on supplies from beyond, according to Dr. Shivute. Namibia’s ability to transform obstacles into opportunities is demonstrated by the hub’s ISO7/ISO8 cleanroom facility, which is the country’s first for medical-grade injection molding.
Unprecedented cooperation between the government, academic institutions, and foreign partners is what made the initiative successful. Prototyping expertise was given by NUST’s FabLab, and crucial money was provided by the EU, German Development Cooperation, and the SADC Secretariat. “Together, Namibia rings loud with progress,” Ms. Tjombonde said, praising the team effort.
The center intends to increase pharmaceutical manufacturing and cut import dependency by 40% by 2030, with plans to certify goods through the Namibia Standards Institute and Namibia Medicines Regulatory Council. This is more than just a factory, as Governor Andre pointed out; it is a ray of hope for an independent Namibia.
The NIP Innovation Hub is a testament to Namibia’s resilience and ambition. By marrying healthcare innovation with industrial growth, the project not only safeguards national health security but also charts a bold course for economic transformation, proof that Namibia’s future is not just imagined, but manufactured at home.
